Idiopathic pulmonary fibrosis (IPF)

Active Ingredient: Pirfenidone

Indication for Pirfenidone

Population group: only adults (18 years old or older)
Therapeutic intent: Curative procedure

Pirfenidone is indicated in adults for the treatment of idiopathic pulmonary fibrosis (IPF).

For this indication, competent medicine agencies globally authorize below treatments:

267 mg 3 times daily for Days 1-7, 534 mg 3 times daily for Days 8-14, 801 mg 3 times daily from Day 15 onwards

For:

Dosage regimens

Oral, 267 milligrams pirfenidone, 3 times daily, over the duration of 7 days. Afterwards, oral, 534 milligrams pirfenidone, 3 times daily, over the duration of 7 days. Afterwards, oral, 801 milligrams pirfenidone, 3 times daily.

Detailed description

Upon initiating treatment, the dose should be titrated to the recommended daily dose of 2403 mg/day over a 14-day period as follows:

  • Days 1 to 7: a dose of 267 mg administered three times a day (801 mg/day)
  • Days 8 to 14: a dose of 534 mg administered three times a day (1602 mg/day)
  • Day 15 onward: a dose of 801 mg administered three times a day (2403 mg/day)

The recommended maintenance daily dose of pirfenidone is 801 mg three times a day with food for a total of 2403 mg/day.

Doses above 2403 mg/day are not recommended for any patient.

Patients who miss 14 consecutive days or more of pirfenidone treatment should re-initiate therapy by undergoing the initial 2-week titration regimen up to the recommended daily dose.

Dosage considerations

It should be taken with food to reduce the possibility of nausea and dizziness.

Active ingredient

Pirfenidone

Pirfenidone attenuates fibroblast proliferation, production of fibrosis-associated proteins and cytokines, and the increased biosynthesis and accumulation of extracellular matrix in response to cytokine growth factors such as, transforming growth factor-beta (TGF-β) and platelet-derived growth factor (PDGF).

Read more about Pirfenidone

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.